Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1
Published June 24, 2020 · Recall initiated: May 27, 2020
Summary
FDA records drug Class II recall D-1303-2020, published June 24, 2020 and initiated May 27, 2020. Recalling firm: Apotex Inc.; Status: Completed; Reported quantity: 305,963 bottles; Lot: All lots remaining within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apotex Inc.
- Distributor
- Nationwide.
- Lot
- All lots remaining within expiry
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMetformin Hydrochloride Extended-Release Tablets, USP 750 mg a) 90 count (NDC 42291-611-90) b) 180 count (NDCJune 24, 2020
- FDABD FACS Sample Prep Assistant (SPA) II - Product Usage: K050191: The BD FACSCanto system with BD FACSCantoJune 17, 2020
- FDAEquate Maximum Strength Ranitidine Tablets, USP 150 mg Acid Reducer 130 Tablets Distributed by Wal-MartNovember 20, 2019
- FDAPiperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only,May 23, 2018
- FDAPiperacillin and Tazobactam for Injection, USP 3.375 gram/vial* 10-count Single Use Vials per carton, Rx Only,May 23, 2018
- FDACycloSPORINE Capsules, USP, 100 mg, 30 count bottle, Rx Only, Manufactured by Apotex, Inc., Toronto, Ontario,March 1, 2017
Questions about this recall
Was Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, 100 count bottles, Rx Only Manufactured by: Apotex, Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326 NDC 60505-0260-1 recalled?
Yes. FDA published recall D-1303-2020 on June 24, 2020. Reported hazard: CGMP Deviations: FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above acceptable intake levels
What should I do if I have this product?
Voluntary: Firm initiated · Press Release